[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 471
Citations 0
Comment & Response
November 15, 2016

Therapy for Cellulitis

Author Affiliations
  • 1Henry Ford Allegiance Health, Jackson, Michigan
JAMA. 2016;316(19):2045-2046. doi:10.1001/jama.2016.15604

To the Editor In their comprehensive review of cellulitis, Drs Raff and Kroshinsky discussed the limited role of culture in making the diagnosis.1 Although a majority of cases of severe nonsuppurative cellulitis (even those presenting with sepsis) are due to β-hemolytic streptococcus,2 antibiotic therapy in the inpatient setting often is unnecessarily broad, covering methicillin-resistant Staphylococcus aureus (MRSA) and various gram-negative bacteria. The lack of culture data can lead to continued extended broad-spectrum antimicrobial use in these patients. The use of serological testing for β-hemolytic streptococcus is underused in this setting but can lead to diagnosis of an etiological agent in up to 40% of these patients, and subsequently, to the fairly rapid simplification of treatment regimen to a narrow-spectrum agent such as penicillin G.24 Use of serologic testing thus has implications both for cost of antimicrobials and effective antimicrobial stewardship.

First Page Preview View Large
First page PDF preview
First page PDF preview
×